Ophthalmoplegia Market Analysis 2014-2017 and 2023 - Research and Markets
The Global Ophthalmoplegia Market Research Report provides detailed
analysis of the key regional market status of the Ophthalmoplegia Industry.
Ophthalmoplegia, also referred as extra
ocular muscle palsy, is a paralysis of the extra ocular muscles that control
movements of eyes. In this condition, nerve fibers that coordinate both eyes in
horizontal movements looking from side to side- are damaged. A number of devices
and treatments are available in the market, which can cure or improve the
eyesight of the patient. The Global Ophthalmoplegia
Market is driven by increasing number of people with ophthalmoplegia
and increasing geriatric population. According to the World Health Organization
in 2010, about 250 million people of over 50 years were suffering from visual
impairment. Around 80% people in many of the developing countries have eye
sight problems; of which nearly 50% of the people are not able to take treatment
due to huge cost of the surgeries. Increasing prevalence of eye sight affecting
diseases, for instance, diabetes and rapid developments in technology have
fuelled the growth of the market. On the other hand, high cost of the treatment
and availability of cheap alternative treatment may slow the growth of the
market.
The global ophthalmoplegia market is expected to grow at a CAGR of ~ 7.2 % during the forecast period 2017-2023.
The global ophthalmoplegia market is expected to grow at a CAGR of ~ 7.2 % during the forecast period 2017-2023.
Ophthalmoplegia Market Top Key Players:
Abbott (US), Novartis AG (Switzerland), ZEISS
International (Germany), Valeant Pharmaceuticals International, Inc. (US),
Amritt, Inc. (US), Medline Industries, Inc. (US), ALLERGAN (Ireland), and
Johnson & Johnson (US).
Ophthalmoplegia Market Segments:
The global Ophthalmoplegia Market has
been segmented on the basis of type, treatment and end user.
On the basis of types, the market is
segmented into external ophthalmoplegia and internuclear ophthalmoplegia.
External ophthalmoplegia is further segmented into superior recti, inferior
recti, medial recti, lateral recti, inferior oblique, and superior oblique
muscles.
On the basis of treatment, the market is
segmented into surgery, drug treatment, and others. The surgery is further
segmented into strabismus surgery and others.
On the basis of end users, the market is
segmented into hospital & clinics, ambulatory clinics, and others.
Ophthalmoplegia Market Regional analysis:
The Americas dominates the global Ophthalmoplegia
Market owing to well-developed technology and increased patient
population with eye sight problem primarily due to increasing prevalence of
diabetes. Additionally, high healthcare expenditure and the presence of some of
the leading players have fuelled the growth of the market in this region.
Europe is the second largest Ophthalmoplegia
Market, which is followed by Asia Pacific. Increasing government
support and availability of funds for research drive the growth of the market.
Asia Pacific is the fastest growing Ophthalmoplegia Market due to
increasing geriatric population and rapidly developing medical sector.
On the other hand, the Middle East &
Africa holds the least share of the market due to limited availability of
medical facilities and poor economic and political conditions in Africa.
Research Methodology:
The report for the global Ophthalmoplegia
Market by Market Research Future comprises of extensive
primary research along with the detailed analysis of qualitative as well as
quantitative aspects by various industry experts, key opinion leaders to gain a
deeper insight of the market and industry performance. The report gives a clear
picture of the current market scenario which includes past and estimated future
market size with respect to value and volume, technological advancement, macro
economical and governing factors in the market. The report provides detail
information about and strategies used by top key players in the industry. The
report also gives a broad study of the different market segments and regions.
Table of Content
1 Report
Prologue
2 Market Introduction
2 Market Introduction
3 Research
Methodology
4 Market Dynamics
5. Market
Factor Analysis
6. Global Ophthalmoplegia Market, By Types
7. Global
Ophthalmoplegia Market, By Treatments
8. Global
Ophthalmoplegia Market, By End Users
9. Global
Ophthalmoplegia Market By Region
10 Company
Landscape
11 Company
Profiles
12 MRFR
Conclusion
About Market Research Future:
At Market Research Future
(MRFR), we enable our customers to unravel the complexity of various industries
through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR),
Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Comments
Post a Comment